Featured News

Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.

Event Post Thumbnail

BIOVECTRA mRNA Vaccine and Bio-manufacturing Facility Announced

18 November 2021

  Charlottetown, P.E.I. (November 18, 2021) – BIOVECTRA today announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of mRNA vaccines and therapeutics – one of the first of its kind in Canada. This exciting new capability will result from a joint private-public investment made by BIOVECTRA and the […]

Read More…

Read More
News Blog page

26 February 2017